Nanomedicine News

RSS

SAIC-Frederick to Assess Ceres' Nanotechnology-Based System Under Agreement

Ceres Nanosciences, LLLP, and National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), have signed a collaboration agreement to a...

22 Apr 2009

Importance of Patient Safety and Risk Management in the Evolving World of Healthcare

CNA understands the importance of patient safety and risk management in the evolving world of healthcare. As one of the nation's leading providers of professional liability insurance for healthcare providers and orga...

21 Apr 2009

Abraxis BioScience Presents Results Reported from Studies Evaluating Tumor Targeting Nanotechnology at AACR Annual Meeting

Abraxis BioScience Inc. (NASDAQ:ABII) today announced that multiple studies showcasing its proprietary tumor targeting technology, known as the nab® (nanoparticle albumin-bound) technology platform, and secreted prot...

21 Apr 2009

Nanotechnology Helping Industry and Consumers Save Money

Nanotechnology has been the talk of science for creating new drug delivery systems and making electronics smaller, but a U.S. company, Industrial Nanotech, Inc. (Ticker: INTK), has brought nanotech down to earth and made...

21 Apr 2009

CombiMatrix Corporation Appoints New Laboratory Director

CombiMatrix Corporation (Nasdaq:CBMX) announced today that Dr. Karine Hovanes has joined its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), as its Laboratory Director. Dr. Hovanes is a Diplomat of the American Board of Medical Genetics in Clinical Molecular Genetics and Clinical Cytogenetics and is also licensed in New York and California in both cytogenetics and molecular genetics.

From Invitae Corporation 21 Apr 2009

Study Demonstrates Proof of Concept for Highly Effective Nanoemulsion Adjuvant Platform Technology

NanoBio Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for the Phase 1 clinical study of NB-1008, a seasonal influenza vaccine administered via a nasal dropper.

20 Apr 2009

Santaris Pharma Announces Promising Findings on the in Vitro and in Vivo Activity of microRNA-Targeted Therapeutics

Santaris Pharma announced today promising findings on the in vitro and in vivo activity of microRNA-targeted therapeutics against cancer developed on the basis of its proprietary Locked Nucleic Acid (LNA) Drug Platform. ...

20 Apr 2009

Better Way to Deliver Cancer Drugs Directly to Tumors by Using Specially Engineered Nanoparticles

An interdisciplinary team of researchers at Brigham and Women's Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology has demonstrated a better way to deliver cancer drugs directly to tumors b...

20 Apr 2009

Nanoparticle Method Designed to Restore Normal Gene Function to Tumor Cells

Dr. Esther Chang describes the most recent developments in human trials of the first systemic, non-viral, tumor-targeted, nanoparticle method designed to restore normal gene function to tumor cells while completely bypas...

20 Apr 2009

MicroRNA Discovery May Lead to New Diagnostic Tests for Cancer

Among their many roles as message couriers and gene regulators, microRNA molecules also help control the repair of damaged DNA within cells, Dana-Farber Cancer Institute and Harvard Medical School scientists report in the May issue of Nature Structural + Molecular Biology.

19 Apr 2009

Nanomedicine News

SAIC-Frederick to Assess Ceres' Nanotechnology-Based System Under Agreement

Importance of Patient Safety and Risk Management in the Evolving World of Healthcare

Abraxis BioScience Presents Results Reported from Studies Evaluating Tumor Targeting Nanotechnology at AACR Annual Meeting

Nanotechnology Helping Industry and Consumers Save Money

CombiMatrix Corporation Appoints New Laboratory Director

Study Demonstrates Proof of Concept for Highly Effective Nanoemulsion Adjuvant Platform Technology

Santaris Pharma Announces Promising Findings on the in Vitro and in Vivo Activity of microRNA-Targeted Therapeutics

Better Way to Deliver Cancer Drugs Directly to Tumors by Using Specially Engineered Nanoparticles

Nanoparticle Method Designed to Restore Normal Gene Function to Tumor Cells

MicroRNA Discovery May Lead to New Diagnostic Tests for Cancer

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials